Galderma Group AG (GALDY)
45.65
-0.67
(-1.45%)
USD |
OTCM |
Nov 13, 16:00
Galderma Group Price : 45.65 for Nov. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 45.80 | 46.04 | 45.60 | 45.65 | 83229.00 |
| Nov 12, 2026 | 46.72 | 46.73 | 46.31 | 46.32 | 59850.00 |
| Nov 11, 2026 | 46.20 | 46.95 | 46.20 | 46.84 | 369990.0 |
| Nov 10, 2026 | 46.29 | 46.29 | 45.51 | 45.82 | 249601.0 |
| Nov 09, 2026 | 45.97 | 46.90 | 45.97 | 46.72 | 125762.0 |
| Nov 06, 2026 | 46.26 | 47.00 | 46.26 | 46.57 | 127345.0 |
| Nov 05, 2026 | 47.75 | 47.92 | 47.36 | 47.41 | 250042.0 |
| Nov 04, 2026 | 47.46 | 47.92 | 46.90 | 47.81 | 83457.00 |
| Nov 03, 2026 | 46.54 | 46.84 | 45.84 | 45.92 | 104354.0 |
| Nov 02, 2026 | 46.99 | 47.00 | 46.41 | 46.58 | 142138.0 |
| Oct 30, 2026 | 46.50 | 46.81 | 46.36 | 46.59 | 106018.0 |
| Oct 29, 2026 | 45.67 | 46.24 | 45.65 | 45.99 | 136747.0 |
| Oct 28, 2026 | 44.43 | 45.07 | 44.43 | 44.78 | 67645.00 |
| Oct 27, 2026 | 46.05 | 46.05 | 44.86 | 44.88 | 308712.0 |
| Oct 26, 2026 | 46.32 | 46.74 | 46.03 | 46.15 | 198660.0 |
| Oct 23, 2026 | 45.71 | 46.42 | 45.62 | 46.30 | 264802.0 |
| Oct 22, 2026 | 45.42 | 45.54 | 44.61 | 45.51 | 120010.0 |
| Oct 21, 2026 | 43.32 | 43.32 | 42.08 | 42.22 | 105588.0 |
| Oct 20, 2026 | 42.78 | 42.78 | 42.34 | 42.45 | 214657.0 |
| Oct 19, 2026 | 42.39 | 42.40 | 41.80 | 41.92 | 263094.0 |
| Oct 16, 2026 | 42.12 | 42.78 | 42.12 | 42.47 | 558441.0 |
| Oct 15, 2026 | 42.26 | 42.26 | 41.25 | 41.58 | 124211.0 |
| Oct 14, 2026 | 40.67 | 41.11 | 40.56 | 41.02 | 98746.00 |
| Oct 13, 2026 | 40.39 | 40.42 | 40.05 | 40.22 | 119285.0 |
| Oct 12, 2026 | 40.33 | 40.54 | 40.06 | 40.25 | 238060.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Novartis AG | 160.50 |
| Roche Holding AG | 60.30 |
| Addex Therapeutics Ltd. | 4.06 |
| Oculis Holding AG | 7.64 |
| Sandoz Group AG | 100.76 |
Price Related Metrics
| PE Ratio | 62.31 |
| PS Ratio | 9.125 |
| Price to Free Cash Flow | 50.95 |
| Earnings Yield | 1.60% |
| Market Cap | 53.23B |
| Operating PE Ratio | 49.24 |
| Normalized PE Ratio | 58.16 |